Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

UNLABELLED: The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13). TRIAL REGISTRATION NUMBER: ISRCTN 34164388.

Original publication

DOI

10.1136/thoraxjnl-2014-205958

Type

Journal article

Journal

Thorax

Publication Date

02/2015

Volume

70

Pages

181 - 182

Keywords

Cytokine Biology, Sleep apnoea, Biomarkers, C-Reactive Protein, Continuous Positive Airway Pressure, Humans, Inflammation, Interleukin-10, Interleukin-6, Patient Compliance, Sleep Apnea, Obstructive, Tumor Necrosis Factor-alpha